Sample results
Bronchiectasis associated with HTLV-I is a respiratory condition where the airways become abnormally widened and damaged. It is caused by infection with Human T-cell Lymphotropic Virus Type I (HTLV-I), which triggers chronic inflammation and immune-mediated airway damage. The Human T-Cell Lymphotropic Virus I, II Antibodies Test with Confirmation is the most important test for diagnosis.
Bronchiectasis associated with HTLV-I is caused by infection with Human T-cell Lymphotropic Virus Type I (HTLV-I), a retrovirus that attacks immune cells. When HTLV-I infects the body, it triggers chronic inflammation and immune system changes that progressively damage the airways over time. This viral infection causes the bronchial tubes to become abnormally widened, scarred, and unable to clear mucus effectively, leading to recurring lung infections and breathing difficulties.
The Human T-Cell Lymphotropic Virus I, II Antibodies Test with Confirmation is the most important blood test for bronchiectasis associated with HTLV-I because it detects antibodies that prove HTLV-I infection. This test includes both preliminary screening and confirmatory testing to ensure accurate identification of the virus causing your airway damage. While bronchiectasis itself is diagnosed through imaging studies like CT scans, this blood test is essential for identifying the underlying viral infection responsible for the condition and guiding appropriate treatment strategies.
You should get tested if you have chronic cough with thick mucus production, recurring lung infections, unexplained shortness of breath, or wheezing that does not improve with standard treatments. Testing is especially important if you have risk factors for HTLV-I infection, such as having lived in endemic areas like Japan, the Caribbean, or parts of Africa and South America, or if you have received blood transfusions before donor screening began. Early testing helps identify the viral cause of your respiratory symptoms and allows for better management of both the infection and airway damage.
What this means
Your test came back negative, meaning no HTLV-I or HTLV-II antibodies were detected in your blood. This is the expected and healthy result, indicating you have not been infected with human T-lymphotropic virus.
Recommended actions
Continue practicing safe sex with barrier protection
Never share needles or drug equipment if you use injection medications
Consider periodic retesting if you remain at higher risk for exposure
Maintain open communication with sexual partners about sexual health
Not overhyped or overpriced. Just comprehensive blood testing made simple and for everyone.
Sample results
Your 24/7 Personal Lab Guide
Quick questions: